Fionnuala Mcaleese-Eser | Group Antibody Discovery Leader
Bayer

Fionnuala Mcaleese-Eser, Group Antibody Discovery Leader, Bayer

Fionnuala received her PhD (Microbiology) from Trinity College Dublin in 2002.  Her post-doctoral studies were carried out at Wyeth Pharmaceuticals (NY) where she worked on S. aureus antibiotic resistance mechanisms.  She then transferred to the Global Biologics organization at Wyeth (Cambridge, MA; acquired by Pfizer in 2009) as a Senior Scientist working primarily with phage display in the antibody lead discovery department with a focus on cancer, inflammatory and infectious diseases.  In 2010, she moved to Heidelberg Germany in a role as Head of Antibody Lead Discovery for Affimed, generating bispecific NK and T-cell engagers for the treatment of cancer.  Since 2013, Fionnuala has been a Group Leader in the Antibody Lead Discovery department within Biologics Research at Bayer with a primary focus on biotherapeutic discovery for cardiovascular indications (Cologne, Germany) and in 2020 she took on a Director level role as head of the Biologics Research Portfolio and Assays department.

Appearances:



Festival of Biologics Day 2 @ 12:00

Antibody lead generation and characterisztion

last published: 01/Jul/22 16:05 GMT

back to speakers